CBPO [China Biologic Products] SC 13D/A: REQUEST FOR STOCKHOLDER CONSENT TO ACTION Ms. Lin

Ticker: CBPO, Company: China Biologic Products, Inc., Type: SC 13D/A, Date: 2012-03-19
Original SEC Filing: Click here


Webplus: CBPO/20120319/SC_13D.A/2_EX-8/000.htm SEC Original: exhibit8.htm
REQUEST FOR STOCKHOLDER CONSENT TO ACTION Ms. Lin Ling Li lll@ctbb.com.cn DATED: MARCH 15, 2012 To : including all pages If you agree with the proposed action by written consent set forth herein, please sign the accompanying written consent which we will notify the Company in accordance with the Delaware General Corporation Law (the “DGCL”). Please return the signed written




Webplus: CBPO/20120319/SC_13D.A/1/000.htm SEC Original: sched13da.htm
SCHEDULE 13D [Rule 13d-101] (Amendment No. 4)* CHINA BIOLOGIC PRODUCTS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 16938C106 (CUSIP Number) No. 14 East Hushan Road Tai’an City, Shandong 271000 People’s Republic of China (86) 538-620-2306 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 14, 2012



Company Information:

Ticker: CBPO, Company: China Biologic Products, Inc., Type: SC 13D/A, Date: 2012-03-19CIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING
BEIJING 100125

Home Page Forums

About the Author:

Leave A Comment

Skip to toolbar